Insulin Resistance, the Metabolic Syndrome, Diabetes, and Cardiovascular Disease Risk in Women with PCOS

Overview

Journal Endocrine

Specialty Endocrinology

Date 2006 Dec 23

PMID 17185791

Citations 40

Authors

H J Teede

S Hutchison

S Zoungas

C Meyer

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome is the most common endocrinopathy of reproductive aged women affecting 6-10% of the population. Traditionally considered a reproductive disorder manifesting as chronic anovulation, infertility, and hyperandrogenism, management has primarily focused on short-term reproductive outcomes. Recently, however, significant metabolic aspects in conjunction with longer-term health sequealae of PCOS have been recognized. The metabolic features are primarily related to underlying insulin resistance (IR), which is now understood to play an important role in both the pathogenesis and long-term sequelae of PCOS.

Citing Articles

Link between iron-mediated lipid peroxidation and polycystic ovary syndrome (PCOS): exploring the genes underlying iron regulatory mechanism.

Hayat N, Akram Z, Khalid N, Ullah N, Mazhar T J Ovarian Res. 2025; 18(1):48.

PMID: 40057801 PMC: 11889770. DOI: 10.1186/s13048-024-01562-6.

The effects of acupuncture on patients with premature ovarian insufficiency and polycystic ovary syndrome: an umbrella review of systematic reviews and meta-analyses.

Bai T, Deng X, Bi J, Ni L, Li Z, Zhuo X Front Med (Lausanne). 2024; 11:1471243.

PMID: 39655237 PMC: 11627218. DOI: 10.3389/fmed.2024.1471243.

The effects of portfolio moderate-carbohydrate and ketogenic diets on anthropometric indices, metabolic status, and hormonal levels in overweight or obese women with polycystic ovary syndrome: a randomized controlled trial.

Sharifi M, Saber A, Moludi J, Salimi Y, Jahan-Mihan A Nutr J. 2024; 23(1):152.

PMID: 39617882 PMC: 11610292. DOI: 10.1186/s12937-024-01056-7.

CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis.

Luo X, Dong Y, Zheng H, Zhou X, Rong L, Liu X J Ovarian Res. 2024; 17(1):79.

PMID: 38610028 PMC: 11015649. DOI: 10.1186/s13048-024-01407-2.

The Metabolic Syndrome, a Human Disease.

Alemany M Int J Mol Sci. 2024; 25(4).

PMID: 38396928 PMC: 10888680. DOI: 10.3390/ijms25042251.

References

Wild R, Bartholomew M . The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am J Obstet Gynecol. 1988; 159(2):423-7. DOI: 10.1016/s0002-9378(88)80099-1. View

Nawrot T, Den Hond E, Fagard R, Hoppenbrouwers K, Staessen J . Blood pressure, serum total cholesterol and contraceptive pill use in 17-year-old girls. Eur J Cardiovasc Prev Rehabil. 2003; 10(6):438-42. DOI: 10.1097/01.hjr.0000103463.31435.1e. View

Gamble G, Zorn J, Sanders G, Macmahon S, Sharpe N . Estimation of arterial stiffness, compliance, and distensibility from M-mode ultrasound measurements of the common carotid artery. Stroke. 1994; 25(1):11-6. DOI: 10.1161/01.str.25.1.11. View

Tsanadis G, Vartholomatos G, Korkontzelos I, Avgoustatos F, Kakosimos G, Sotiriadis A . Polycystic ovarian syndrome and thrombophilia. Hum Reprod. 2002; 17(2):314-9. DOI: 10.1093/humrep/17.2.314. View

Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J . Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995; 26(6):956-60. DOI: 10.1161/01.str.26.6.956. View

Haffner S . The insulin resistance syndrome revisited. Diabetes Care. 1996; 19(3):275-7. DOI: 10.2337/diacare.19.3.275. View

Bray G . Medical consequences of obesity. J Clin Endocrinol Metab. 2004; 89(6):2583-9. DOI: 10.1210/jc.2004-0535. View

Lakhani K, Hardiman P, Seifalian A . Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries. Atherosclerosis. 2004; 175(2):353-9. DOI: 10.1016/j.atherosclerosis.2004.04.007. View

Dahlgren E, Janson P, Johansson S, Lapidus L, Lindstedt G, Tengborn L . Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril. 1994; 61(3):455-60. View

10.

OMeara N, Blackman J, Ehrmann D, Barnes R, Jaspan J, Rosenfield R . Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993; 76(5):1241-7. DOI: 10.1210/jcem.76.5.8496316. View

11.

Koskinen P, Manttari M, Manninen V, HUTTUNEN J, Heinonen O, FRICK M . Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care. 1992; 15(7):820-5. DOI: 10.2337/diacare.15.7.820. View

12.

Gossain V, Sherma N, MICHELAKIS A, ROVNER D . Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels. Am J Obstet Gynecol. 1983; 147(6):618-23. DOI: 10.1016/0002-9378(83)90437-4. View

13.

Ferrari P, Weidmann P . Insulin, insulin sensitivity and hypertension. J Hypertens. 1990; 8(6):491-500. DOI: 10.1097/00004872-199006000-00001. View

14.

Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Horio T, Yoshimasa Y . Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am J Hypertens. 2004; 17(3):228-32. DOI: 10.1016/j.amjhyper.2003.11.013. View

15.

Salonen J, Salonen R . Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991; 11(5):1245-9. DOI: 10.1161/01.atv.11.5.1245. View

16.

Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C . Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987; 2(8549):3-9. DOI: 10.1016/s0140-6736(87)93050-9. View

17.

Prelevic G, Wurzburger M, Trpkovic D . Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome. Gynecol Endocrinol. 1990; 4(3):157-68. DOI: 10.3109/09513599009009803. View

18.

Zimmermann S, Phillips R, Dunaif A, Finegood D, Wilkenfeld C, Ardeljan M . Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab. 1992; 75(2):508-13. DOI: 10.1210/jcem.75.2.1639952. View

19.

Pradhan A, Cook N, Buring J, Manson J, Ridker P . C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003; 23(4):650-5. DOI: 10.1161/01.ATV.0000065636.15310.9C. View

20.

LaRosa J . Reduction of serum LDL-C levels: a relationship to clinical benefits. Am J Cardiovasc Drugs. 2004; 3(4):271-81. DOI: 10.2165/00129784-200303040-00006. View